We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+40.41%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$1.93B
AUM Growth
+$710M
Cap. Flow
+$347M
Cap. Flow %
17.99%
Top 10 Hldgs %
33.69%
Holding
94
New
31
Increased
15
Reduced
22
Closed
18

Top Buys

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$61.8M
2
LH icon
Labcorp
LH
+$50M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$48.9M
4
AZN icon
AstraZeneca
AZN
+$32.8M
5
HOLX
Hologic
HOLX
+$30.1M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$38.5M
2
BDX icon
Becton Dickinson
BDX
+$34.7M
3
CI icon
Cigna
CI
+$34.5M
4
ELV icon
Elevance Health
ELV
+$33.1M
5
COR icon
Cencora
COR
+$30M

Sector Composition

Rank Sector Weight
1 Healthcare 66.7%
2 Technology 4.27%
3 Consumer Discretionary 1.32%
4 Industrials 0.62%
5 Financials 0.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMMU
1
DELISTED
Immunomedics Inc
IMMU
$113M 5.84%
3,178,974
+2,114,933
+199% +$61.8M
ALXN
2
DELISTED
Alexion Pharmaceuticals
ALXN
$76.2M 3.95%
678,884
-7,365
-1% -$782K
QQQ icon
3
PUT
Invesco QQQ Trust
QQQ
$469B
$69.2M 3.59%
+279,400
New +$62.6M
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$63.5M 3.29%
+1,142,478
New +$48.9M
ABBV icon
5
AbbVie
ABBV
$448B
$63.3M 3.28%
644,588
-79,586
-11% -$7.01M
BMRN icon
6
BioMarin Pharmaceuticals
BMRN
$11.3B
$59.6M 3.09%
483,079
+83,474
+21% +$8.3M
GILD icon
7
Gilead Sciences
GILD
$162B
$51.8M 2.69%
673,412
+120,073
+22% +$9.2M
LH icon
8
Labcorp
LH
$23.1B
$51.5M 2.67%
+361,224
New +$50M
MCK icon
9
McKesson
MCK
$95.3B
$50.5M 2.62%
329,175
-14,775
-4% -$2.13M
XBI icon
10
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$49M 2.54%
+438,100
New +$43.1M
CAH icon
11
Cardinal Health
CAH
$51.7B
$45.2M 2.34%
865,933
-12,598
-1% -$649K
RCUS icon
12
Arcus Biosciences
RCUS
$3.77B
$42.9M 2.23%
1,735,581
+926,070
+114% +$25M
ICUI icon
13
ICU Medical
ICUI
$3.93B
$41.6M 2.16%
225,551
+23,212
+11% +$4.61M
IQV icon
14
IQVIA
IQV
$33.1B
$40.8M 2.12%
287,538
+130,337
+83% +$17.7M
KRTX
15
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$39.3M 2.04%
352,545
-146,965
-29% -$12.8M
ABBV icon
16
CALL
AbbVie
ABBV
$448B
$36M 1.87%
+366,800
New +$32.3M
HOLX
17
DELISTED
Hologic
HOLX
$35M 1.81%
+613,776
New +$30.1M
AZN icon
18
AstraZeneca
AZN
$263B
$33.6M 1.74%
+317,800
New +$32.8M
AERI
19
DELISTED
Aerie Pharmaceuticals
AERI
$33.6M 1.74%
2,274,220
-254,056
-10% -$3.76M
HUM icon
20
Humana
HUM
$47.7B
$33.4M 1.73%
86,020
-17,010
-17% -$6.36M
HRTX icon
21
Heron Therapeutics
HRTX
$88.5M
$32.8M 1.7%
2,231,402
-250,515
-10% -$4.12M
HCA icon
22
HCA Healthcare
HCA
$82.5B
$32M 1.66%
329,357
+143,508
+77% +$14.9M
CNST
23
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$31.6M 1.64%
1,051,390
+735,496
+233% +$26.5M
DHR icon
24
Danaher
DHR
$126B
$30.5M 1.58%
+194,378
New +$27.9M
IRTC icon
25
iRhythm Holdings
IRTC
$3.49B
$28.8M 1.49%
248,558
+15,149
+6% +$1.67M
1
2 3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return

PFM Health Sciences's Q2 2020 Portfolio in Review

As of Q2 2020, PFM Health Sciences held 94 positions worth $1.93B, up 58% from $1.22B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

PFM Health Sciences deployed $347M of net new capital in Q2 2020, opening 31 new positions and adding to 15 existing holdings. Its largest new stake was Labcorp: 361,224 shares worth $51.5M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, down from 84% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Elevance Health, an estimated $33.1M trimmed.

  • PFM Health Sciences's largest Q2 2020 buy was Labcorp: 361,224 shares worth $51.5M.
  • PFM Health Sciences added most to Immunomedics Inc in Q2 2020, an estimated $61.8M increase.
  • PFM Health Sciences's biggest Q2 2020 reduction was Elevance Health, cutting an estimated $33.1M.
  • PFM Health Sciences fully exited Pfizer in Q2 2020, selling an estimated $38.5M.
  • PFM Health Sciences's ten largest holdings make up 34% of its $1.93B portfolio in Q2 2020.
  • PFM Health Sciences opened 31 new positions and closed 18 in Q2 2020.
  • PFM Health Sciences's portfolio value rose 58% quarter-over-quarter to $1.93B.

Based on PFM Health Sciences's 13F filing for Q2 2020, filed 14 Aug 2020.